Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation

Daniel R. Principe, Brian DeCant, Jonas Staudacher, Dominic Vitello, Riley J. Mangan, Elizabeth A. Wayne, Emman Mascariñas, Andrew M. Diaz, Jessica Bauer, Ronald D. McKinney, Khashayarsha Khazaie, Boris Pasche, David W. Dawson, Hidayatullah G. Munshi, Paul J. Grippo, Barbara Jung

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

TGFβ has both tumor suppressive and tumor promoting effects in colon cancer. Also, TGFβ can affect the extent and composition of inflammatory cells present in tumors, contextually promoting and inhibiting inflammation. While colon tumors display intratumoral inflammation, the contributions of TGFβ to this process are poorly understood. In human patients, we found that epithelial loss of TGFβ signaling was associated with increased inflammatory burden; yet overexpression of TGFβ was also associated with increased inflammation. These findings were recapitulated in mutant APC models of murine tumorigenesis, where epithelial truncation of TGFBR2 led to lethal inflammatory disease and invasive colon cancer, mediated by IL8 and TGFβ1. Interestingly, mutant APC mice with global suppression of TGFβ signals displayed an intermediate phenotype, presenting with an overall increase in IL8-mediated inflammation and accelerated tumor formation, yet with a longer latency to the onset of disease observed in mice with epithelial TGFBR-deficiency. These results suggest that the loss of TGFβ signaling, particularly in colon epithelial cells, elicits a strong inflammatory response and promotes tumor progression. This implies that treating colon cancer patients with TGFβ inhibitors may result in a worse outcome by enhancing inflammatory responses.

Original languageEnglish (US)
Pages (from-to)3826-3839
Number of pages14
JournalOncotarget
Volume8
Issue number3
DOIs
StatePublished - 2017

Keywords

  • Colon cancer
  • Inflammation
  • TGF-beta

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation'. Together they form a unique fingerprint.

  • Cite this

    Principe, D. R., DeCant, B., Staudacher, J., Vitello, D., Mangan, R. J., Wayne, E. A., Mascariñas, E., Diaz, A. M., Bauer, J., McKinney, R. D., Khazaie, K., Pasche, B., Dawson, D. W., Munshi, H. G., Grippo, P. J., & Jung, B. (2017). Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation. Oncotarget, 8(3), 3826-3839. https://doi.org/10.18632/oncotarget.9830